Abstract
In this chapter recombinant FSH, follicle-stimulating hormone, products are discussed. Over the years, several different FSH products were introduced, i.e. follitropin alfa, follitropin beta, follitropin delta and corifollitropin alfa. Structural aspects that affect the performance of these highly glycosylated proteins are explained.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
De Leeuw R, Mulders J, Voortman G, Rombout F, Damm J, Kloosterboer L (1996) Structure-function relationship of recombinant follicle stimulating hormone (Puregon®). Mol Hum Reprod 2:361–369
Devroey P, Boostanfar R, Koper NP, Ijzerman P, Mannaerts BMJL, Fauser BC, ENGAGE Investigators (2009) A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod 24:3063–3072
European public assessment report Gonal-F (Follitropin alfa), CPMP/415/95. Revision 18, 11 Apr 2011. European Agency for the Evaluation of Medicinal Products
Fares FA, Suganuma N, Nishimori K, LaPolt PS, Hsueh AJ, Boime I (1992) Design of a long-acting follitropin agnosit by fusinh the C-terminal sequence of the beta chorionic gonadotropin subunit. Proc Natl Acad Sci USA 89:4304–4308
Fauser BCJM, Mannaerts BMJL, Devroey P, Leader A, Boime I, Baird DT (2009) Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Hum Reprod Update 15:309–321
Fauser BCJM, Alper MM, Ledger W, Schoolcraft WB, Zandvliet A, Mannaerts BMJL (2010) Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during controlled ovarian stimulation for in vitro fertilisation. Reprod Biomed Online 21:593–601
Howles CM (1996) Genetic engineering of human FSH (Gonal-F®). Hum Reprod Update 2:172–191
LaPolt PS, Nishimori K, Fares FA, Perlas E, Boime I, Hsueh AJ (1992) Enhanced stimulation of follicle stimulating and ovulatory potential by long acting follicle stimulating hormone agonist with extended carboxy-termial peptide. Endocrinology 131:2514–2520
Mannaerts BMJL, De Leeuw R, Geelen J, Van Ravenstein A, Van Wezenbeek P, Schuurs A, Kloosterboer L (1992) Comparative in vitro and in vivo studies on the biological properties of recombinant human follicle stimulating hormone. Endocrinology 129:2623–2630
Matzuk MM, Hsueh AJ, Lapolt P, Tsafriri A, Keene JL, Boime I (1990) The biological role of the carboxy-terminal extension of human chorionic gonadotropin (corrected) beta-subunit. Endocrinology 126:376–383
Norman RJ, Zegers-Hochschild F, Salle BS, Elbers J, Heijnen E, Marintcheva-Petrova M, Mannaerts B (2011) Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity. Hum Reprod 26(8):2200–2208
Olijve W, de Boer W, Mulders JWM, van Wezenbeek PMGF (1996) Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon
®). Mol Hum Reprod 2:371–382Olson H, Standström R, Grundemar L (2014) Different pharmacokinetic and pharmodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line. J Clin Pharmacol 54:1299–1307
Rettenbacher M, Andersen AN, Garcia-Velasco JA, Sator M, Barri P, Lindenberg S, van der Veen K, Khalaf Y, Bentin-Ley U, Obruca A, Tews G, Schenk M, Stowitzki T, Narvekar N, Sator K, Inthurn B (2015) A multi-center phase 3 study comparing efficacy and safety of Bemfola versus Gonal-F in women undergoing ovarian stimulation for ivf. Reprod Biomed Online 30:504–513
van Wezenbeek P, Draaier J, van Meel F, Olijve W (1990) Recombinant follicle stimulating hormone. I. Construction, selection and characterization of a cell line. In: Crommelin DJA, Schellekens H (eds) From clone to clinic, Developments in biotherapy, vol 1. Kluwer, Dordrecht, pp 245–251
Verbost P, Sloot WN, Rose UM, de Leeuw R, Hanssen RGJM, Verheijden GFM (2011) Pharmacologic profiling of corifollitropin alfa, the first developed sustained follicle stimulant. Eur J Pharmacol 651:227–233
Voortman G, van de Post J, Schoemaker RC, Gerwen J v (1999) Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon®) by Pen-injector and syringe. Hum Reprod 14:1698–1702
Suggested Reading
Seyhan A, Ata B (2011) The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist. Int J Women’s Health 3:243–255
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sam, T., de Leeuw, R. (2019). Follicle-Stimulating Hormone. In: Crommelin, D., Sindelar, R., Meibohm, B. (eds) Pharmaceutical Biotechnology. Springer, Cham. https://doi.org/10.1007/978-3-030-00710-2_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-00710-2_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-00709-6
Online ISBN: 978-3-030-00710-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)